GPS News  
EPIDEMICS
European nations tighten virus curbs as Christmas surge fears grow
By Deborah Cole with AFP Bureaus
Berlin (AFP) Dec 16, 2020

French group's test distinguishes flu and Covid
Lyon (AFP) Dec 16, 2020 - French medical diagnostics company bioMerieux said Wednesday it had received certification to sell a test capable of distinguishing regular flu from Covid-19 and two other respiratory illnesses with similar symptoms.

The company believes the test will help sufferers and doctors diagnose their illness more quickly, which could potentially save lives.

After receiving the European "CE" regulatory marking, the test will be available in Europe and other countries that recognise this certification.

Fran�ois Lacoste, head of research and development at bioMerieux, said he believed the tests "have a key role to play with the onset of winter and the flu season."

Using a nasal swab, the kits can detect flu types A and B and Covid-19, as well as human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).

China's Fosun Pharma to import 100 million BioNTech vaccine doses
Beijing (AFP) Dec 16, 2020 - A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.

China has been rapidly developing its own Covid-19 vaccine candidates and ramping up production facilities, but local firms have also been partnering with foreign developers to supply the world's most populous country.

Shanghai Fosun Pharmaceutical Group said its subsidiary had entered into an agreement with the German firm aimed at ensuring "an adequate supply" of vaccines in China, adding it will make an initial payment of 125 million euros ($152 million) before year-end for 50 million doses.

Fosun Pharma said it would pay the remaining 125 million euros after receiving authorisation to commercialise the German vaccine in mainland China.

The agreement did not detail when the remaining 50 million doses would arrive.

Pfizer and BioNTech's mRNA vaccine has already been approved for emergency use in countries such as the US, the UK and Singapore.

Its vaccine is based on cutting-edge technology that uses synthetic versions of molecules called messenger RNA to hack into human cells, and effectively turn them into vaccine-making factories.

Beijing has five vaccines in the final stages of development, saying at least a million people were to receive a jab after vaccine candidates were approved for emergency use.

China has been inking agreements to supply millions of doses of Chinese-made vaccines to other countries after largely bringing the outbreak under control at home.

On Tuesday, health officials in one county of northern Heilongjiang province -- where officials have been battling a small number of cases -- said they would start offering Covid-19 vaccine doses to the general public.

The jabs wil cost 420 yuan ($64), but the statement did not clarify which vaccine was being offered.

Three of China's five vaccine products that are in the final stages of development use an inactivated form of the novel coronavirus to boost immunity.

Fosun Pharma is majority-owned by Fosun International, a Chinese conglomerate that owns France-based resort giant Club Med and travel firm Thomas Cook.

Several European countries tightened restrictions and Germany registered a record death toll on the first day of its new lockdown Wednesday, as the United States set a new daily record of Covid-19 infections.

The tougher measures came as EU members agreed to start coronavirus vaccinations on the same day.

European Commission chief Ursula von der Leyen told European deputies: "To get to the end of the pandemic, we will need up to 70 percent of the population vaccinated.

"This is a huge task, a big task. So let's start as soon as possible with the vaccination together, as 27, with a start at the same day."

Pressure has been mounting on the bloc to catch up with Britain and the United States who have both started their programmes, using a vaccine made in the EU jointly by Pfizer and BioNTech.

Several European countries on Wednesday imposed tighter coronavirus restrictions ahead of Christmas.

Swathes of England came under stricter curbs, and Denmark extended its restrictions.

France and Turkey have also announced restrictions over the holiday season, and on Tuesday, the Netherlands shut down schools and non-essential shops for five weeks.

Germany also closed non-essential shops and schools on Wednesday, as its Robert Koch Institute announced that a record 952 people had died of coronavirus in the previous 24 hours.

- Pressure for vaccine approval -

Germany, which coped relatively well with the first wave in the spring, has struggled to contain a surge in recent months.

Its health minister has joined calls on the European Union's health regulator to approve the Pfizer-BioNTech vaccine "before Christmas".

Although Britain has already started using it, high infection numbers forced London on Wednesday to join large parts of central and northern England under tough, economically painful restrictions.

Pubs, bars, restaurants and other hospitality sites will close, apart from takeaways, as will theatres and other entertainment venues.

"The hospitality business needs this week, and it's devastating. It is devastatingly awful," said Lesley Lewis, owner of The French House, a London pub.

"But if this is what it takes to save lives, that's what we have to do."

A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.

Hopes for an end to the pandemic have also been boosted by positive assessments of the Moderna Covid-19 vaccine.

- New measures from US -

The US Food and Drug Administration on Tuesday issued an upbeat briefing about Moderna, ahead of a meeting of experts on whether to grant it emergency approval.

The United States has already started using the Pfizer-BioNTech vaccine, and on Tuesday the FDA also approved the country's first rapid at-home coronavirus test for Covid-19. Available over-the-counter, it produces a result in around 20 minutes.

The need is urgent, as the United States remains the hardest-hit nation, setting a record for new daily infections on Tuesday with more than 248,000 cases.

The Washington National Cathedral rang its bells 300 times Tuesday in memory of the 300,000 people who have lost their lives to coronavirus in the United States. The current toll stands at 303,797.

In California, officials ordered 5,000 extra body bags as Los Angeles was left with fewer than 100 available intensive care beds for a county of 10 million people.

"I don't want... to scare folks" said Governor Gavin Newsom. "But this is a deadly disease, and we need to be mindful of where we are."

President-elect Joe Biden has said that he will be vaccinated in public.

- Poorer nations left behind? -

Worldwide, more than 73.4 million infections and over 1.6 million deaths have been recorded so far.

But with wealthy nations reserving more than half of next year's potential doses, there are fears the poorer parts of the world will be left behind.

Even if the drug makers all produce effective, safe vaccines and meet their maximum global manufacturing targets, a study published Wednesday by researchers from Johns Hopkins University warned that "at least a fifth of the world's population would not have access" until 2022.

The World Health Organization has said it is in talks with Pfizer and Moderna about including their vaccines at affordable prices for poor countries.

burs-jj/wdb

PFIZER

BioNTech


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Health centre water crisis increasing virus risk: WHO
Geneva (AFP) Dec 14, 2020
One in four health centres worldwide lacks access to water, putting around 1.8 billion people at increased risk of contracting the coronavirus, the World Health Organization said Monday. The lack of this basic amenity endangers patients and staff alike at such centres, the WHO said in a joint report with the UN children's agency UNICEF. The study was based on data from 165 countries. "Working in a healthcare facility without water, sanitation and hygiene is akin to sending nurses and doctors to ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
China's Yangtze fishing communities adapt to life on land

Urine diversion shows multiple environmental benefits when used at city scale

Nobel-winning UN food agency warns of 'hunger pandemic' worse than Covid

High-tech fixes for the food system could have unintended consequences

EPIDEMICS
Atom-thin transistor uses half the voltage of common semiconductors, boosts current density

Energy-efficient magnetic RAM: A new building block for spintronic technologies

An LED that can be integrated directly into computer chips

Discovery suggests new promise for nonsilicon computer transistors

EPIDEMICS
United Airlines aims to offset emissions by 2050 via carbon capture

NASA's Supersonic X-59 Assembly Team Marks Wing Milestone

DARPA Gremlins Project Completes Third Flight Test Deployment

Beating the heat: Oxidation in novel coating material for aircraft gas turbine engines

EPIDEMICS
Poland taps coal region for first electric car plant

Uber rival Ola to build world's biggest scooter factory in India

VW set to miss EU emissions targets: CEO

Japan set to ban sales of new petrol cars in mid-2030s: reports

EPIDEMICS
US charges tire company with evading tariffs on China

Pound rises on Brexit talks extension, vaccine lifts stocks

Asian markets fall as virus surge leads to new lockdowns

Asian markets fall as virus surge leads to new lockdowns

EPIDEMICS
Storing carbon through tree planting, preservation costs more than thought

Deforestation in Brazilian Amazon surges to 12-year high

Bolsonaro slams 'unjustified' attacks over Amazon deforestation

Concrete jungle threatens mangroves on Pakistan island

EPIDEMICS
The natural 'Himalayan aerosol factory' can affect climate

Swedish Space Corporation invests in UK Swedish start-up Globaltrust

Beyond Ice: NASA's ICESat-2 shows hidden talents

Teledyne e2v wins UK grant to develop AI processes for intelligent EO detection systems

EPIDEMICS
Weak force has strong impact on nanosheets

Making 3D nanosuperconductors with DNA

Researchers share design for affordable single-molecule microscope

Scientists explain the paradox of quantum forces in nanodevices









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.